eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2014
vol. 10
 
Share:
Share:
abstract:

Original paper
Direct transcatheter aortic valve implantation – one-year outcome of a case control study

Janusz Kochman
,
Łukasz Kołtowski
,
Zenon Huczek
,
Piotr Scisło
,
Leopold Bakoń
,
Radosław Wilimski
,
Bartosz Rymuza
,
Grzegorz Opolski

Postep Kardiol Inter 2014; 10, 4 (38): 250–257
Online publish date: 2014/11/17
View full text Get citation
 
Introduction: Transaortic valve implantation (TAVI) has a well-established position in the treatment of high-risk and inoperable patients with severe aortic stenosis (AS). The TAVI protocol requires a pre-dilatation for native valve preparation.

Aim: To assess the safety and feasibility of TAVI without pre-dilatation and to compare it with the procedure with pre-dilatation.

Material and methods: Out of 101 TAVI patients, in 10 the procedure was performed without balloon predilatation, and 8 patients were included in the analysis. The procedural, echocardiographic, and clinical outcomes were compared with a case control matched cohort (1 : 2 ratio). A 12-month follow-up was done in all cases.

Results: The procedure was successfully completed in all patients in the study group (SG), but there was one procedural failure in the control group (CG). All patients received a CoreValve (Medtronic) bioprosthesis. There was a significant immediate decrease in transvalvular gradients (TG) in both study arms after the procedure (SG: mean TG: from 46.0 ±14.0 mm Hg to 10.0 ±4.8 mm Hg, p < 0.001; CG: mean TG: from 55.9 ±12.0 mm Hg to 9.9 ±2.9 mm Hg, p < 0.001). A marked increase in the effective orifice areas was observed in both cohorts (SG: 1.63 ±0.13 cm2 and CG: 1.67 ±0.25 cm2, p = 0.75). The periprocedural complication rate was equally distributed in both arms. The 12-month all-cause mortality was 12.5% in both groups.

Conclusions: The direct TAVI approach seams to be safe and feasible. The clinical and echocardiographic results are not different from those achieved in patients treated with standard TAVI protocol with pre-dilatation.
keywords:

transaortic valve implantation, pre-dilatation, no pre-dilatation, aortic valve, balloon valvuloplasty

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.